Pathogenetic therapy of systemic scleroderma
- Authors: Salikhov I.G.1, Bodrova R.A.1, Ziganshina L.E.1
-
Affiliations:
- Kazan State Medical University
- Issue: Vol 82, No 5 (2001)
- Pages: 406-409
- Section: Articles
- URL: https://journals.rcsi.science/kazanmedj/article/view/84126
- DOI: https://doi.org/10.17816/kazmj84126
- ID: 84126
Cite item
Full Text
Abstract
Systemic scleroderma (SSD) is a progressive polysyndromic disease with characteristic changes in the skin, musculoskeletal system, internal organs and widespread vasospastic disorders based on connective tissue lesions with predominant vascular fibrosis of the type of obliterating endarteriolitis.
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
I. G. Salikhov
Kazan State Medical University
Author for correspondence.
Email: info@eco-vector.com
Russian Federation
R. A. Bodrova
Kazan State Medical University
Email: info@eco-vector.com
Russian Federation
L. E. Ziganshina
Kazan State Medical University
Email: info@eco-vector.com
Russian Federation
References
